Nitazoxanide for mild to moderate ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with mild or moderate ulcerative colitis (UC) confirmed by colonoscopy or biopsy.
- You are not pregnant or breastfeeding.
- You do not have colorectal cancer.
- You are not currently taking steroid medications, immune-suppressing drugs, or biologic treatments for UC.
- You do not have a history of alcohol or drug addiction, and you are not allergic to the study medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests adding a medicine called mebendazole (normally used for parasites) to standard mesalamine treatment for people with mild or moderate ulcerative colitis. The goal is to see if it helps control inflammation better than mesalamine alone.
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.
This trial tests whether adding febuxostat, a medicine usually used for gout, can help reduce inflammation in people with mild to moderate ulcerative colitis who are already taking mesalamine. It aims to see if this combination is safe and effective.
This trial tests if the drug pentoxifylline can help people with mild to moderate ulcerative colitis. It may offer a new treatment option for those not on other strong medications.
This study tests whether adding nitazoxanide, an anti-parasitic medicine, to your current ulcerative colitis treatment helps reduce inflammation and symptoms. It may offer an extra option for people with mild-to-moderate disease.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.